NEW YORK, March 9 (GenomeWeb News) - MDS today reported that instrument sales during its fiscal first quarter declined 4 percent to $71 million from $74 million for the year-ago period.
Profits for MDS Sciex also fell to $19 million from $21 million in the first quarter of 2005, a 9.5-percent decline. The company said the decrease was "principally due to currency."
MDS said that the best-selling products in its Sciex unit were the API 5000, the 4800 MALDI/Tof/TOF, and the 3200 Qtrap. MDS Sciex shipped the first CellKey system produced at the new Singapore facility in the quarter.